Annual EBIT
-$498.32 M
-$63.40 M-14.58%
31 December 2023
Summary:
Legend Biotech annual earnings before interest & taxes is currently -$498.32 million, with the most recent change of -$63.40 million (-14.58%) on 31 December 2023. During the last 3 years, it has fallen by -$190.23 million (-61.75%). LEGN annual EBIT is now -32385.27% below its all-time high of $149.00 thousand.LEGN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$115.38 M
-$102.90 M-824.09%
30 September 2024
Summary:
Legend Biotech quarterly earnings before interest & taxes is currently -$115.38 million, with the most recent change of -$102.90 million (-824.09%) on 30 September 2024. Over the past year, it has dropped by -$58.56 million (-103.07%). LEGN quarterly EBIT is now -831.10% below its all-time high of -$12.39 million, reached on 31 March 2019.LEGN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$323.17 M
-$58.56 M-22.13%
30 September 2024
Summary:
Legend Biotech TTM earnings before interest & taxes is currently -$323.17 million, with the most recent change of -$58.56 million (-22.13%) on 30 September 2024. Over the past year, it has increased by +$165.02 million (+33.80%). LEGN TTM EBIT is now -2507.92% below its all-time high of -$12.39 million, reached on 31 March 2019.LEGN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LEGN EBIT Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -14.6% | -103.1% | +33.8% |
3 y3 years | -61.8% | +7.8% | +13.5% |
5 y5 years | -10000.0% | -316.4% | -371.4% |
LEGN EBIT High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -61.8% | at low | -824.1% | +40.4% | -22.1% | +37.0% |
5 y | 5 years | <-9999.0% | at low | -824.1% | +40.4% | -371.4% | +37.0% |
alltime | all time | <-9999.0% | at low | -831.1% | +40.4% | -2507.9% | +37.0% |
Legend Biotech EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$115.38 M(+824.1%) | -$323.17 M(+22.1%) |
June 2024 | - | -$12.49 M(-77.0%) | -$264.61 M(-40.6%) |
Mar 2024 | - | -$54.31 M(-61.5%) | -$445.78 M(-10.5%) |
Dec 2023 | -$498.32 M(+14.6%) | -$140.99 M(+148.1%) | -$498.32 M(+2.1%) |
Sept 2023 | - | -$56.82 M(-70.7%) | -$488.19 M(-4.8%) |
June 2023 | - | -$193.65 M(+81.2%) | -$512.93 M(+0.4%) |
Mar 2023 | - | -$106.86 M(-18.3%) | -$510.71 M(+17.4%) |
Dec 2022 | -$434.93 M(+7.0%) | -$130.86 M(+60.5%) | -$434.93 M(+5.4%) |
Sept 2022 | - | -$81.56 M(-57.4%) | -$412.79 M(-9.6%) |
June 2022 | - | -$191.43 M(+515.9%) | -$456.41 M(+28.0%) |
Mar 2022 | - | -$31.08 M(-71.4%) | -$356.52 M(-15.1%) |
Dec 2021 | -$406.30 M | -$108.72 M(-13.2%) | -$420.00 M(+12.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2021 | - | -$125.18 M(+36.8%) | -$373.67 M(+18.5%) |
June 2021 | - | -$91.53 M(-3.2%) | -$315.45 M(-12.1%) |
Mar 2021 | - | -$94.56 M(+51.6%) | -$358.71 M(+16.4%) |
Dec 2020 | -$308.09 M(+136.7%) | -$62.39 M(-6.8%) | -$308.09 M(+0.3%) |
Sept 2020 | - | -$66.96 M(-50.3%) | -$307.30 M(+14.6%) |
June 2020 | - | -$134.79 M(+206.7%) | -$268.04 M(+65.8%) |
Mar 2020 | - | -$43.95 M(-28.7%) | -$161.70 M(+24.2%) |
Dec 2019 | -$130.15 M(+8384.2%) | -$61.60 M(+122.3%) | -$130.15 M(+89.9%) |
Sept 2019 | - | -$27.71 M(-2.6%) | -$68.55 M(+67.9%) |
June 2019 | - | -$28.45 M(+129.6%) | -$40.84 M(+229.6%) |
Mar 2019 | - | -$12.39 M | -$12.39 M |
Dec 2018 | -$1.53 M | - | - |
FAQ
- What is Legend Biotech annual earnings before interest & taxes?
- What is the all time high annual EBIT for Legend Biotech?
- What is Legend Biotech annual EBIT year-on-year change?
- What is Legend Biotech quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Legend Biotech?
- What is Legend Biotech quarterly EBIT year-on-year change?
- What is Legend Biotech TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Legend Biotech?
- What is Legend Biotech TTM EBIT year-on-year change?
What is Legend Biotech annual earnings before interest & taxes?
The current annual EBIT of LEGN is -$498.32 M
What is the all time high annual EBIT for Legend Biotech?
Legend Biotech all-time high annual earnings before interest & taxes is $149.00 K
What is Legend Biotech annual EBIT year-on-year change?
Over the past year, LEGN annual earnings before interest & taxes has changed by -$63.40 M (-14.58%)
What is Legend Biotech quarterly earnings before interest & taxes?
The current quarterly EBIT of LEGN is -$115.38 M
What is the all time high quarterly EBIT for Legend Biotech?
Legend Biotech all-time high quarterly earnings before interest & taxes is -$12.39 M
What is Legend Biotech quarterly EBIT year-on-year change?
Over the past year, LEGN quarterly earnings before interest & taxes has changed by -$58.56 M (-103.07%)
What is Legend Biotech TTM earnings before interest & taxes?
The current TTM EBIT of LEGN is -$323.17 M
What is the all time high TTM EBIT for Legend Biotech?
Legend Biotech all-time high TTM earnings before interest & taxes is -$12.39 M
What is Legend Biotech TTM EBIT year-on-year change?
Over the past year, LEGN TTM earnings before interest & taxes has changed by +$165.02 M (+33.80%)